Literature DB >> 35943138

COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).

Wan Yang1, Jeffrey L Shaman2.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) have been key drivers of new coronavirus disease 2019 (COVID-19) pandemic waves. To better understand variant epidemiologic characteristics, here we apply a model-inference system to reconstruct SARS-CoV-2 transmission dynamics in South Africa, a country that has experienced three VOC pandemic waves (i.e. Beta, Delta, and Omicron BA.1) by February 2022. We estimate key epidemiologic quantities in each of the nine South African provinces during March 2020 to February 2022, while accounting for changing detection rates, infection seasonality, nonpharmaceutical interventions, and vaccination. Model validation shows that estimated underlying infection rates and key parameters (e.g. infection-detection rate and infection-fatality risk) are in line with independent epidemiological data and investigations. In addition, retrospective predictions capture pandemic trajectories beyond the model training period. These detailed, validated model-inference estimates thus enable quantification of both the immune erosion potential and transmissibility of three major SARS-CoV-2 VOCs, that is, Beta, Delta, and Omicron BA.1. These findings help elucidate changing COVID-19 dynamics and inform future public health planning.
© 2022, Yang and Shaman.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; epidemiology; global health; immune evasion; none; reinfection rate; transmissibility; variant of concern

Mesh:

Year:  2022        PMID: 35943138      PMCID: PMC9363123          DOI: 10.7554/eLife.78933

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  47 in total

1.  A global database of COVID-19 vaccinations.

Authors:  Edouard Mathieu; Hannah Ritchie; Esteban Ortiz-Ospina; Max Roser; Joe Hasell; Cameron Appel; Charlie Giattino; Lucas Rodés-Guirao
Journal:  Nat Hum Behav       Date:  2021-05-10

2.  Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021.

Authors:  Lin T Brandal; Emily MacDonald; Lamprini Veneti; Tine Ravlo; Heidi Lange; Umaer Naseer; Siri Feruglio; Karoline Bragstad; Olav Hungnes; Liz E Ødeskaug; Frode Hagen; Kristian E Hanch-Hansen; Andreas Lind; Sara Viksmoen Watle; Arne M Taxt; Mia Johansen; Line Vold; Preben Aavitsland; Karin Nygård; Elisabeth H Madslien
Journal:  Euro Surveill       Date:  2021-12

3.  Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.

Authors: 
Journal:  Lancet       Date:  2022-02-24       Impact factor: 202.731

4.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.

Authors:  Nick Andrews; Julia Stowe; Freja Kirsebom; Samuel Toffa; Tim Rickeard; Eileen Gallagher; Charlotte Gower; Meaghan Kall; Natalie Groves; Anne-Marie O'Connell; David Simons; Paula B Blomquist; Asad Zaidi; Sophie Nash; Nurin Iwani Binti Abdul Aziz; Simon Thelwall; Gavin Dabrera; Richard Myers; Gayatri Amirthalingam; Saheer Gharbia; Jeffrey C Barrett; Richard Elson; Shamez N Ladhani; Neil Ferguson; Maria Zambon; Colin N J Campbell; Kevin Brown; Susan Hopkins; Meera Chand; Mary Ramsay; Jamie Lopez Bernal
Journal:  N Engl J Med       Date:  2022-03-02       Impact factor: 91.245

5.  Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.

Authors:  Emma C Wall; Mary Wu; Ruth Harvey; Gavin Kelly; Scott Warchal; Chelsea Sawyer; Rodney Daniels; Philip Hobson; Emine Hatipoglu; Yenting Ngai; Saira Hussain; Jerome Nicod; Robert Goldstone; Karen Ambrose; Steve Hindmarsh; Rupert Beale; Andrew Riddell; Steve Gamblin; Michael Howell; George Kassiotis; Vincenzo Libri; Bryan Williams; Charles Swanton; Sonia Gandhi; David Lv Bauer
Journal:  Lancet       Date:  2021-06-03       Impact factor: 79.321

6.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).

Authors:  Ruiyun Li; Sen Pei; Bin Chen; Yimeng Song; Tao Zhang; Wan Yang; Jeffrey Shaman
Journal:  Science       Date:  2020-03-16       Impact factor: 47.728

7.  Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.

Authors:  Wan Yang; Sasikiran Kandula; Mary Huynh; Sharon K Greene; Gretchen Van Wye; Wenhui Li; Hiu Tai Chan; Emily McGibbon; Alice Yeung; Don Olson; Anne Fine; Jeffrey Shaman
Journal:  Lancet Infect Dis       Date:  2020-10-19       Impact factor: 25.071

8.  Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.

Authors:  Nicole Wolter; Waasila Jassat; Sibongile Walaza; Richard Welch; Harry Moultrie; Michelle Groome; Daniel Gyamfi Amoako; Josie Everatt; Jinal N Bhiman; Cathrine Scheepers; Naume Tebeila; Nicola Chiwandire; Mignon du Plessis; Nevashan Govender; Arshad Ismail; Allison Glass; Koleka Mlisana; Wendy Stevens; Florette K Treurnicht; Zinhle Makatini; Nei-Yuan Hsiao; Raveen Parboosing; Jeannette Wadula; Hannah Hussey; Mary-Ann Davies; Andrew Boulle; Anne von Gottberg; Cheryl Cohen
Journal:  Lancet       Date:  2022-01-19       Impact factor: 202.731

9.  Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.

Authors:  Raquel Viana; Sikhulile Moyo; Daniel G Amoako; Houriiyah Tegally; Cathrine Scheepers; Christian L Althaus; Ugochukwu J Anyaneji; Phillip A Bester; Maciej F Boni; Mohammed Chand; Wonderful T Choga; Rachel Colquhoun; Michaela Davids; Koen Deforche; Deelan Doolabh; Louis du Plessis; Susan Engelbrecht; Josie Everatt; Jennifer Giandhari; Marta Giovanetti; Diana Hardie; Verity Hill; Nei-Yuan Hsiao; Arash Iranzadeh; Arshad Ismail; Charity Joseph; Rageema Joseph; Legodile Koopile; Sergei L Kosakovsky Pond; Moritz U G Kraemer; Lesego Kuate-Lere; Oluwakemi Laguda-Akingba; Onalethatha Lesetedi-Mafoko; Richard J Lessells; Shahin Lockman; Alexander G Lucaci; Arisha Maharaj; Boitshoko Mahlangu; Tongai Maponga; Kamela Mahlakwane; Zinhle Makatini; Gert Marais; Dorcas Maruapula; Kereng Masupu; Mogomotsi Matshaba; Simnikiwe Mayaphi; Nokuzola Mbhele; Mpaphi B Mbulawa; Adriano Mendes; Koleka Mlisana; Anele Mnguni; Thabo Mohale; Monika Moir; Kgomotso Moruisi; Mosepele Mosepele; Gerald Motsatsi; Modisa S Motswaledi; Thongbotho Mphoyakgosi; Nokukhanya Msomi; Peter N Mwangi; Yeshnee Naidoo; Noxolo Ntuli; Martin Nyaga; Lucier Olubayo; Sureshnee Pillay; Botshelo Radibe; Yajna Ramphal; Upasana Ramphal; James E San; Lesley Scott; Roger Shapiro; Lavanya Singh; Pamela Smith-Lawrence; Wendy Stevens; Amy Strydom; Kathleen Subramoney; Naume Tebeila; Derek Tshiabuila; Joseph Tsui; Stephanie van Wyk; Steven Weaver; Constantinos K Wibmer; Eduan Wilkinson; Nicole Wolter; Alexander E Zarebski; Boitumelo Zuze; Dominique Goedhals; Wolfgang Preiser; Florette Treurnicht; Marietje Venter; Carolyn Williamson; Oliver G Pybus; Jinal Bhiman; Allison Glass; Darren P Martin; Andrew Rambaut; Simani Gaseitsiwe; Anne von Gottberg; Tulio de Oliveira
Journal:  Nature       Date:  2022-01-07       Impact factor: 49.962

Review 10.  The changing epidemiology of SARS-CoV-2.

Authors:  Katia Koelle; Michael A Martin; Rustom Antia; Ben Lopman; Natalie E Dean
Journal:  Science       Date:  2022-03-10       Impact factor: 63.714

View more
  4 in total

1.  COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).

Authors:  Wan Yang; Jeffrey L Shaman
Journal:  Elife       Date:  2022-08-09       Impact factor: 8.713

2.  A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.

Authors:  Juan Shi; Jian Zheng; Wanbo Tai; Abhishek K Verma; Xiujuan Zhang; Qibin Geng; Gang Wang; Xiaoqing Guan; Moffat M Malisheni; Abby E Odle; Wei Zhang; Fang Li; Stanley Perlman; Lanying Du
Journal:  J Virol       Date:  2022-08-16       Impact factor: 6.549

3.  Testing for COVID-19 is Much More Effective When Performed Immediately Prior to Social Mixing.

Authors:  Chad R Wells; Senay Gokcebel; Abhishek Pandey; Alison P Galvani; Jeffrey P Townsend
Journal:  Int J Public Health       Date:  2022-07-27       Impact factor: 5.100

4.  Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.

Authors:  Yan Niu; Li Luo; Shiting Yang; Guzainuer Abudurusuli; Xiaoye Wang; Zeyu Zhao; Jia Rui; Zhuoyang Li; Bin Deng; Weikang Liu; Zhe Zhang; Kangguo Li; Chan Liu; Peihua Li; Jiefeng Huang; Tianlong Yang; Yao Wang; Tianmu Chen; Qun Li
Journal:  Front Public Health       Date:  2022-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.